INNV FINANCIAL STATEMENTS

InnovAge Holding Corp — balance sheet, income statement and cash flow trends

INNVInnovAge Holding Corp

🇺🇸 USA · NASDAQ · Healthcare · Medical Care Facilities

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue945.9 M $+13.7%

Gross Profit196.2 M $+31.8%

Operating Income37 M $—

EBITDA4.4 M $—

Net Income-22.2 M $—

Peer Comparison· Medical Care Facilities

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
INNV	13.7%	20.7%	0.5%	-2.3%
SIA	16.7%	15.2%	17.2%	4.3%
MPARK	13.0%	28.1%	27.7%	10.1%
REG	14.2%	11.2%	13.5%	3.0%
SNZ	13.3%	42.8%	47.9%	72.0%
RYM	215.1%	-5.9%	-21.8%	-60.1%
Industry median	10.2%	27.7%	13.8%	3.7%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
INNV	13.7%	20.7%	0.5%	-2.3%
HCSG	6.5%	13.6%	5.2%	3.7%
AGL	-2.8%	-2.7%	-5.9%	-6.4%
PNTG	36.8%	14.8%	5.9%	3.0%
ADUS	19.6%	32.5%	11.1%	6.9%
AMN	19.9%	27.6%	5.9%	-0.9%
Industry median	10.2%	27.7%	13.8%	3.7%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity229 M $44%
Current Liabilities195.9 M $38%
Long-term Liabilities92.6 M $18%

Key Figures

YoY change

Total Assets547.4 M $+2.0%

Total Liabilities288.5 M $+7.3%

Total Equity229 M $-3.8%

Cash & ST Investments138.6 M $+36.2%

Total Debt93.8 M $-11.0%

Net Debt-1.7 M $-103.8%

Peer Comparison· Medical Care Facilities

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
INNV	1.03	41.0%	-10.28	41.8%
SIA	0.60	165.1%	6.97	32.1%
MPARK	1.19	50.0%	0.92	46.9%
REG	0.09	-26.7%	-1.12	-1.2%
SNZ	0.34	59.6%	11.44	36.0%
RYM	0.55	39.0%	-6.24	33.2%
Industry median	1.26	59.9%	1.87	35.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
INNV	1.03	41.0%	-10.28	41.8%
HCSG	3.11	2.9%	-1.70	63.1%
AGL	1.04	18.4%	0.58	12.1%
PNTG	1.19	130.9%	7.46	36.2%
ADUS	1.83	12.4%	0.22	77.7%
AMN	1.09	109.0%	1.07	27.4%
Industry median	1.26	59.9%	1.87	35.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow50.3 M $+95.3%

Capital Expenditures11.4 M $+16.8%

Free Cash Flow38.9 M $+143.1%

Dividends Paid——

Peer Comparison· Medical Care Facilities

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
INNV	5.3%	4.1%	1.2%	-226.4%
SIA	13.6%	1.2%	12.4%	312.7%
MPARK	17.8%	-1.7%	14.8%	175.9%
REG	31.0%	18.6%	12.4%	1,023.5%
SNZ	137.8%	87.4%	50.4%	191.5%
RYM	36.5%	31.3%	5.2%	-60.7%
Industry median	10.4%	5.8%	3.6%	165.7%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
INNV	5.3%	4.1%	1.2%	-226.4%
HCSG	8.7%	8.4%	0.3%	237.4%
AGL	-0.9%	-1.3%	0.5%	13.4%
PNTG	6.5%	4.6%	1.8%	218.1%
ADUS	10.0%	9.5%	0.5%	145.3%
AMN	21.6%	20.7%	1.0%	-2,278.5%
Industry median	10.4%	5.8%	3.6%	165.7%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on INNV

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.